Immuneering: Funding, Investors & Team (Oct 2026)
Immuneering is a biopharmaceutical company that uses its expertise in translational bioinformatics to enhance outcomes for patients with cancer and neurological disorders. With over ten years of experience, the company applies its knowledge to all aspects of drug development, gaining valuable insights into how drugs work and how patients respond to treatment.
Immuneering has raised $62.2M across 2 funding rounds on record, the most recent an undisclosed round of $25.0M announced in Aug 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Immuneering Company Profile and Key Stats
Latest funding round on record: Aug 2025.
Immuneering Funding Rounds
Immuneering raised $37.2M in an undisclosed round announced in Jan 2021.
4.6 years later, an undisclosed round of $25.0M was announced in Aug 2025.
Immuneering Founders and Leadership Team
Contact details for the Immuneering team: 1 of 1 has an email address on file.
Start 14-day free trial →Immuneering Funding Compared to Other Biotechnology Startups
Immuneering's latest round of $25.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Immuneering in Biotechnology and Cambridge
Companies Similar to Immuneering
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Immuneering Funding FAQs
What does Immuneering do?
Immuneering is a biopharmaceutical company that uses its expertise in translational bioinformatics to enhance outcomes for patients with cancer and neurological disorders. With over ten years of experience, the company applies its knowledge to all aspects of drug development, gaining valuable insights into how drugs work and how patients respond to treatment.
How much funding has Immuneering raised?
Immuneering has raised $62.2M across 2 rounds on record. The most recent is an undisclosed round of $25.0M announced in Aug 2025.
When did Immuneering last raise funding?
Immuneering's most recent funding round on record is an undisclosed round of $25.0M, announced in Aug 2025.
Who founded Immuneering?
FundedIQ lists Ben Zeskind (Founder) at Immuneering.
Where is Immuneering headquartered?
Immuneering is based in Cambridge, Massachusetts, United States.
How many employees does Immuneering have?
Immuneering is in the 51-100 employee band.
How does Immuneering's funding compare to other Biotechnology startups?
Immuneering's latest round of $25.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Immuneering Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Immuneering is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.